skip to the main content

Get Ready for Your Next Normal with Our Total Solutions COVID-19

Boditech COVID-19 Total Solution

Rapid Diagnostic Test (RDT) Solution

Boditech Quick™ rapid diagnostic tests enable everyone and healthcare professionals to execute COVID-19-related tests more quickly and effectively in environments where the analytical instrument is difficult to use. With easy-to-use operation, it can detect COVID-19 with naked eyes in a short time.

Boditech Quick™ COVID-19 Ag Boditech Quick™ COVID-19 Ag Nasal Boditech Quick™ COVID-19 Ag Saliva Boditech Quick™ COVID-19 Neutralizing Ab

Diagnosis of COVID-19 Infection

The total solution for COVID-19 by Boditech Med provides a simple, quick, and accurate test results for SARS-CoV-2 infection.

PCR(NuActor, ExAmplar) Antigen(ichroma™, AFIAS) Antibody(ichroma™, AFIAS)

Provided by
Boditech Med

Related References

Our Products


About RDT
Rapid diagnostic tests (RDTs) have been increasingly applied across health care settings and have been helpful in assisting diagnosis and treatment. Especially, due to the simple procedure and reliable test results in the field, RDTs made lower dependency on the laboratories. COVID-19 related RDTs will provide appropriate levels of disease prevention to the general public and patients as they are very useful for the public location such as community health centers and schools directly.

Neutralizing Antibody

About Neutralizing Antibody
The conventional test for neutralizing antibodies requires the 'Plaque Reduction Neutralization Test (PRNT)', which requires high-level biosecurity for virus tests and strict protocols not to mention the considerable amount of time. The COVID-19 Neutralizing Ab (nAb) kit performs the equivalent task without resorting to PRNT, which should help medical professionals to make a timely decision on the treatment planning.


About Antigen (Influenza combo)
These products help to isolate the infected person and provide accurate antiviral treatment by quickly and simply distinguishing between the presence or absence of SARS-COV-2 infection as well as fatal respiratory diseases (COVID-19 and flu) with similar clinical symptoms faster than PCR.